During the past decade, Kursk Regional Oncologic Dispensary conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 3 clinical trials were completed, i.e. on average, 150% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 2 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Kursk Regional Oncologic Dispensary" #1 collaborator was "Foundation Medicine" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Kursk Regional Oncologic Dispensary" are "Carcinoma, Non-Small-Cell Lung" (2 trials), "Colorectal Cancer" (1 trials), "Epithelial Ovarian Cancer" (1 trials), "Fallopian Tube Cancer" (1 trials) and "Ovarian Cancer" (1 trials). Many other conditions were trialed in "Kursk Regional Oncologic Dispensary" in a lesser frequency.

Most popular intervention types in "Kursk Regional Oncologic Dispensary" are "Drug" (5 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "Simtuzumab" (2 trials), "Avastin" (1 trials), "BI 695502" (1 trials), "BIBF 1120 plus docetaxel" (1 trials) and "Chemotherapy" (1 trials). Other intervention names were less common.

The vast majority of trials in "Kursk Regional Oncologic Dispensary" are 4 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Kursk Regional Oncologic Dispensary". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in Kursk Regional Oncologic Dispensary, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Kursk Regional Oncologic Dispensary, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".